2-叔丁基硫基-1,3-苯并噻唑 | 39543-16-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 2-叔丁基硫基-1,3-苯并噻唑
• 英文名称: 2(tert-butylthio)benzo[d]thiazole
• 英文别名: BENZOTHIAZOLE, 2-(tert-BUTYLTHIO)-；2-tert-butylsulfanyl-1,3-benzothiazole
• CAS: 39543-16-3
• 化学式: C₁₁H₁₃NS₂
• mdl: MFCD00553120
• 分子量: 223.363
• InChiKey: OBNJMMOIUUIFCV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  66.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  2-叔丁基硫基-1,3-苯并噻唑 在 对甲苯磺酸 作用下， 以 邻二氯苯 为溶剂， 反应 0.33h， 以91%的产率得到2-巯基苯并噻唑
  参考文献：
  名称：

  Becher, Jan; Lundsgaard, John, Phosphorus and Sulfur and the Related Elements, 1982, vol. 14, p. 131 - 138

  摘要：

  DOI：
• 作为产物：
  描述：

  苯并噻唑 在 sodium hydride 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 1.5h， 生成 2-叔丁基硫基-1,3-苯并噻唑
  参考文献：
  名称：

  噻唑-2-基-盐对噻唑的选择性CH硫族化作用。

  摘要：

  噻唑和苯并噻唑通过噻唑的C2-官能化与膦进行序列选择性的C2-H硫族化，生成phospho盐，然后与S和Se中心的亲核试剂反应生成C2-H的硫族化产物，并可以回收起始膦。原子经济序列在温和条件下进行，并且对亲核体（富电子，贫电子，空间受阻的硫醇）和各种取代的苯并噻唑都具有广阔的范围。获得取代的与医学相关的C 2-硫代苯并噻唑的方法也使得改进的茱莉亚烯化反应中的立体选择性得以改善。

  DOI：

  10.1039/d0ob00684j

文献信息

• Dioxanes and uses thereof
  申请人：——

  公开号：US20040072849A1

  公开（公告）日：2004-04-15

  In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I): 1 and pharmaceutically acceptable derivatives thereof, wherein R 1 , R 2 , R 3 , n, X and Y are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. The present invention further provides compounds capable of inhibiting histone deacetylatase activity and methods for treating disorders regulated by histone deacetylase activity (e.g., cancer and protozoal infections) comprising administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof. The present invention additionally provides methods for modulating the glucose-sensitive subset of genes downstream of Ure2p. The present invention also provides methods for preparing compounds of the invention.

  鉴于需要开发新型治疗剂和有效的合成方法，本发明提供了一般式(I)的新化合物： 1 及其药学上可接受的衍生物，其中R 1 ，R 2 ，R 3 ，n，X和Y如本文所定义。本发明还提供了包含一种式(I)化合物和药学上可接受的载体的药物组合物。本发明还提供了能够抑制组蛋白去乙酰化酶活性的化合物以及治疗由组蛋白去乙酰化酶活性调节的疾病的方法（例如，癌症和原虫感染），包括向需要的受体施用一种式(I)化合物的治疗有效量。本发明还提供了调节Ure2p下游葡萄糖敏感基因子集的方法。本发明还提供了制备本发明化合物的方法。
• Synthesis of 2-Thio-Substituted Benzothiazoles via a Domino Condensation/<i>S</i>-Arylation/Heterocyclization Process
  作者：Liu Shi、Xiangqian Liu、Hui Zhang、Yongwen Jiang、Dawei Ma

  DOI：10.1021/jo200535e

  日期：2011.5.20

  Condensation of carbon disulfide with thiols in the presence of K2CO3 generates carbonotrithioate salts in situ, which undergo coupling with 2-iodoanilines and subsequent intramolecular condensation and elimination under assistance of CuBr to afford 2-thio-substituted benzothiazoles. Both aliphatic and aromatic thiols are compatible with this process, delivering the corresponding heterocycles with

  在K 2 CO 3存在下，二硫化碳与硫醇的缩合原位生成三硫代碳酸盐，将其与2-碘苯胺偶联，随后在CuBr的帮助下进行分子内缩合和消除，得到2-硫基取代的苯并噻唑。脂族和芳族硫醇均与该过程相容，从而提供具有良好多样性的相应杂环。
• A New Method for the Preparation of Alkyl Aryl Sulfides from Alcohols via Alkoxydiphenylphosphines by Oxidation–Reduction Condensation
  作者：Teruaki Mukaiyama、Kazuhiro Ikegai

  DOI：10.1246/cl.2004.1522

  日期：2004.11

  A new method for the preparation of alkyl aryl sulfides from alcohols via alkoxydiphenylphosphines by oxidation-reduction condensation was established. Various primary, secondary, and tertiary alcohols were successfully converted into the corresponding sulfides in moderate to high yields.

  建立了烷氧基二苯基膦氧化还原缩合醇合成烷基芳基硫化物的新方法。各种伯醇、仲醇和叔醇以中等至高产率成功转化为相应的硫化物。
• HISTONE DEACETYLASE INHIBITORS
  申请人：Bradner James Elliot

  公开号：US20100056588A1

  公开（公告）日：2010-03-04

  In recognition of the need to develop novel therapeutic agents, the present invention provides novel histone deacetylase inhibitors. These compounds include an ester bond making them sensitive to deactivation by esterases. Therefore, these compounds are particularly useful in the treatment of skin disorders. When the compounds reaches the bloodstream, an esterase or an enzyme with esterase activity cleaves the compound into biologically inactive fragments or fragments with greatly reduced activity Ideally these degradation products exhibit a short serum and/or systemic half-life and are eliminated rapidly. These compounds and pharmaceutical compositions thereof are particularly useful in treating cutaneous T-cell lymphoma, neurofibromatosis, psoriasis, hair loss, skin pigmentation, and dermatitis, for example. The present invention also provides methods for preparing compounds of the invention and intermediates thereto.

  为了开发新型治疗剂，本发明提供了新型组蛋白去乙酰化酶抑制剂。这些化合物包括酯键，使它们对酯酶的失活敏感。因此，这些化合物在治疗皮肤疾病方面特别有用。当这些化合物进入血液循环时，酯酶或具有酯酶活性的酶将其裂解成生物学上不活性的碎片或具有大大降低活性的碎片。理想情况下，这些降解产物表现出短的血清和/或系统半衰期，并迅速被排出体外。这些化合物及其制剂在治疗切除性T细胞淋巴瘤、神经纤维瘤、银屑病、脱发、皮肤色素沉着和皮炎等方面特别有用。本发明还提供了制备本发明化合物及其中间体的方法。
• TRITERPENE SAPONINS, METHODS OF SYNTHESIS, AND USES THEREOF
  申请人：Gin David

  公开号：US20110300177A1

  公开（公告）日：2011-12-08

  The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and clinical evaluation.

  本发明涉及三萜糖苷皂苷衍生的佐剂、其合成、中间体及其用途。QS-7是一种强效的免疫佐剂，其毒性显著低于QS-21，QS-21是目前在抗癌和抗病毒疫苗中被广泛使用的相关皂苷佐剂。繁琐的分离和纯化方案阻碍了QS-7的临床开发。本发明提供了一种新的半合成方法，其中使用水解的原皂苷混合物来合成QS-7、QS-21和相关的类似物，极大地促进了QS-7和QS-21类似物的临床前和临床评估。